Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1997-1-16
pubmed:abstractText
Enoxacin, an antimicrobial fluoroquinolone with a 7-piperazinyl-1, 8-naphthyridine skeleton, is a potent inhibitor of cytochrome P-450-mediated theophylline metabolism. The present study was designed to clarify, using seven enoxacin derivatives, the molecular characteristics of the fluoroquinolone responsible for the inhibition. Three derivatives with methyl-substituted 7-piperazine rings inhibited rat liver microsomal theophylline metabolism to 1,3-dimethyluric acid to an extent similar to that of enoxacin (50% inhibitory concentrations [IC50s] = 0.39 to 0.48 mM). 7-Piperazinyl-quinoline derivatives, 8-hydroenoxacin (8-Hy) and 1-cyclopropyl-8-fluoroenoxacin (8-F1), which have a hydrogen and a fluorine at position 8, respectively, more weakly inhibited metabolite formation (IC50s = 0.88 and 1.29 mM, respectively). Little inhibition (IC50 > 2 mM) was observed in those with 3'-carbonyl and 4'-N-acetyl groups on the piperazine rings. The substrate-induced difference spectra demonstrated that the affinities of enoxacin, 8-Hy, and 8-F1 to cytochrome P-450 were parallel with their inhibitory activities. The substituent at position 8 was found to determine the molecular conformations of the fluoroquinolones, and the planarity in molecular shape decreased in the same order as the inhibitory activity (enoxacin > 8-Hy > 8-F1). Moreover, the 3'-carbonyl and 4'-N-acetyl groups decreased the basicity of their vicinal 4'-nitrogen atoms when judged from their electrostatic potentials, which showed a remarkably broadened negative charge around the nitrogens. As a result, the planarity of the whole molecule and the basicity of the 4'-nitrogen atom of enoxacin are likely to be dominant factors in the inhibition of theophylline metabolism by cytochrome P-450.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-1246012, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-1346993, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-1929255, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-193841, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-1993167, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-2342057, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-2344166, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-2737798, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-2757677, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-3164618, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-3477409, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-3567014, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-3729975, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-3867394, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-4066706, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-518689, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-6034578, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-6145999, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-6277939, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-6408394, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-6422043, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-6798990, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-7452690, http://linkedlifedata.com/resource/pubmed/commentcorrection/8843297-8429824
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1875-80
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Structure-related inhibitory effect of antimicrobial enoxacin and derivatives on theophylline metabolism by rat liver microsomes.
pubmed:affiliation
Department of Pharmacokinetics, Dainippon Pharmaceutical Co., Ltd., Osaka, Japan.
pubmed:publicationType
Journal Article